The clinical relevance of treating social phobia

Journal of Affective Disorders

Volumn 50, Issue SUPPL. 1, 1998, Pages

  Lader, Malcolm ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Disability; Social phobia; Treatment

Indexed keywords

BROFAROMINE; SEROTONIN UPTAKE INHIBITOR;

BEHAVIOR THERAPY; COGNITIVE THERAPY; CONFERENCE PAPER; DAILY LIFE ACTIVITY; DRUG EFFICACY; HUMAN; LIFE SATISFACTION; PHYSICAL DISABILITY; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; RECEPTOR BLOCKING; SOCIAL INTERACTION; SOCIAL PHOBIA;

HUMANS; PHOBIC DISORDERS; QUALITY OF LIFE; SEROTONIN UPTAKE INHIBITORS; TREATMENT OUTCOME;

EID: 0031751933     PISSN: 01650327     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-0327(98)00091-3     Document Type: Conference Paper

References (30)

1. Brown, T.A., Barlow, D.H., 1992. Comorbidity among anxiety disorders: Implications for treatment and DSM-IV. J. Consult. Clin. Psychology. 60, 835-844.
2. Burton, R., 1621. The Anatomy of Melancholy, Reprint 1977, J.M. Dent and Sons, London, Toronto.
3. Davidson, J.R., Miner, C.M., De Veaugh-Geiss, J., Tupler, L.A., Colket, J.T., Potts, N.L., 1997. The Brief Social Phobia Scale: A psychometric evaluation. Psychol Med. 27, 161-166.
4. Davidson, J.R.T., Hughes, D.L., George, L.K., Blazer, D.G., 1993. The epidemiology of social phobia: Findings from the Duke Epidemiological Catchment Area Study. Psychol. Med. 23, 709-718.
5. Davidson, J.R.T., Hughes, D.C., George, L.K., Blazer, D.G., 1994. The boundary of social phobia. Arch. Gen. Psychiatry. 51, 975-983.
6. Davidson, J.R.T., Potts, N.L.S., Richichi, E.A., Ford, S.M., Krishnan, K.R.R., Smith, R.D., Wilson, W., 1991. The Brief Social Phobia Scale. J. Clin Psychiatry. 52 (Suppl.), 48-51.
7. Den Boer, J.A., Van Vliet, I.M., Westenberg, H.G.M., 1994. Recent advances in the psychopharmacology of social phobia. Prog. Neuro-Psychopharmacol. Biol. Psychiatry. 18, 625-645.
8. Fahlen, T., Nilsson, H.L., Borg, K., Humble, M., Pauli, U., 1995. Social phobia: The clinical efficacy and tolerability of the monoamine oxidase-A and serotonin uptake inhibitor brofaromine. Acta Psychiatr. Scand. 92, 351-358.
9. Gergel, I., Pitts, C., Oakes, R., Kumar, R., 1997. Significant improvement in symptoms of social phobia after paroxetine treatment. Biol. Psychiatry. 42 (26S), Abs. 14-12.
10. Greist, J.H., 1995. The diagnosis of social phobia. Clin. Psychiatry 56(5), 5-12.
11. Heimberg, R.G., Juster, H.R., 1994. Treatment of social phobia in cognitive-behavioral groups. J. Clin. Psychiatry. 55 (Suppl. 6), 38-46.
12. Jefferson, J.W, 1995. Social phobia: A pharmacologic treatment overview. J. Clin. Psychiatry. 56 (Suppl. 5), 1824.
13. Katzelnick, D.J., Kobak, K.A., Greist, J.H., Jefferson, J.W., Mantle, J.M., Serlin, R.C., 1995. Sertraline for social phobia: A double-blind, placebo-controlled crossover study. Am. J. Psychiatry. 152, 1368-1371.
14. Liebowitz, M.R., 1987. Social phobia. In: Ban, T.A., Pichot, P., Poldinger, W. (Eds.), Modern Problems of Pharmacopsychiatry, Karger, Switzerland., Vol. 22, pp. 141-173.
15. Liebowitz, M.R., Gorman, J.M., Fyer, A.J., Klein, D.F., 1985. Social phobia: Review of a neglected anxiety disorder. Arch. Gen. Psychiatry. 42, 729-736.
16. Liebowitz, M.R., 1993. Pharmacotherapy of social phobia. J. Clin. Psychiatry. 54, 31-35.
17. Mancini, C., Van Ameringen, M.V., 1996. Paroxetine in social phobia. J. Clin. Psychiatry. 57, 519-522.
18. Marshall, R.D., Schneier, F.R., Fallon, B.A., Feerick, J., Liebowitz, M.R., 1994. Medication therapy for social phobia. J. Clin. Psychiatry. 55 (Suppl. 6), 33-37.
19. Munjack, D., Flowers, C., 1994. Zoloft (sertraline) in the treatment of social phobia. Poster presented at CINP, June 1994, Washington, DC.
20. Rapee, R.M., Lim, L., 1992. Discrepancy between self- and observer ratings of performance in social phobics. J. Abnorm. Psychol. 101, 728-731.
21. Ross, J.R., 1991. Social phobia: The Anxiety Disorders Association of America helps raise the veil of ignorance. J. Clin. Psychiatry. 52, 43-47.
22. Safren, S.A., Heimberg, R.G., Brown, E.J., Holle, C., 1997. Quality of life in social phobia. Depress. Anx. 4, 126-133.
23. Schneier, F.R., Johnson, J., Hornig, C.D., Liebowitz, M.R., Weissman, M.M., 1992. Social phobia: Comorbidity and morbidity in an epidemiologic sample. Arch. Gen. Psychiatry. 49, 282-288.
24. Schneier, F.R., Heckelman, L.R., Garfinkel, R., Campeas, R., Fallon, B.A., Gitow, A., Street, L., Del Bene, D., Liebowitz, R., 1994. Functional impairment in social phobia. J. Clin. Psychiatry. 55, 322-331.
25. Sheehan, D.V., Harnett-Sheehan, K., Raj, B.A., 1996. The measurement of disability. Int. Clin. Psychopharmacol. 11 (Suppl. 3), 89-95.
26. Stein, M.B., Chartier, M.J., Hazen, A.L., Kroft, C.D., Chale, R.A., Cots, D., Walker, J.R., 1996. Paroxetine in the treatment of generalized social phobia: Open-label treatment and double-blind placebo-controlled discontinuation. J. Clin. Psychopharmacol. 16, 218-222.
27. Tancer, M.E., Uhde, T.W., 1995. Social phobia. A review of pharmacological treatment. CNS Drugs. 3, 267-278.
28. Van Ameringen, M., Mancini, C., Streiner, D., 1994. Sertraline in social phobia. J. Affect. Disord. 31, 141-145.
29. Van Vliet, I.M., den Boer, J.A., Westenberg, H.G., 1994. Psychopharmacological treatment of social phobia: A double-blind, placebo-controlled study with fluvoxamine. Psychopharmacology. 115, 128-134.
30. Versiani, M., Nardi, A.E., Mundim, F.D., Alves, A.B., Liebowitz, M.R., Amrein, R., 1992. Pharmacotherapy of social phobia - A controlled study with moclobemide and phenelzine. Br. J. Psychiatry. 161, 353-360.